Get started
Work

Supplementary Figure 9B from Somatic Epigenetic Silencing of RIPK3 Inactivates Necroptosis and Contributes to Chemoresistance in Malignant Mesothelioma

Year: 2023
Type: supplementary-materials
Abstract: Drug sensitivity differences between 12 RIPK3-negative and 3 RIPK3-positive human MM cell lines as assessed by MTS assay. Treatment of MM cell lines with three different doses of doxorubicin. First three bars in each bar graph represent viability of RIPK3-positive (+) MM cell lines, M49, M29 and M217, respectively. The bars shown to the right in each graph represent the viability of each of the 12 RIPK3-negative (-) MM lines. All drug treatments were for 72 h.
DOI: 10.1158/1078-0432.22473972.v1
Authors: Yinfei Tan, Eleonora Sementino, Mitchell Cheung, Suraj Peri, Craig W. Menges, Anna-Mariya Kukuyan, Ting Zhang, Vladimir Khazak, Lauren A. Fox, Eric A. Ross, Suresh Ramanathan, Suresh C. Jhanwar, Raja M. Flores, Siddharth Balachandran, Joseph R. Testa
Language: English
Open Access status: gold
OpenAlex ID: W4361936203
Cites:
Cited by:
Related to: 10